Dissecting molecular mechanisms of resistance to NOTCH1-targeted therapy in T-cell acute lymphoblastic leukemia xenografts

Despite substantial progress in treatment of T-cell acute lymphoblastic leukemia (T-ALL), mortality remains relatively high, mainly due to primary or acquired resistance to chemotherapy. Further improvements in survival demand better understanding of T-ALL biology and development of new therapeutic...

Descripción completa

Detalles Bibliográficos
Autores principales: Agnusdei, Valentina, Minuzzo, Sonia, Pinazza, Marica, Gasparini, Alessandra, Pezzè, Laura, Amaro, Adriana Agnese, Pasqualini, Lorenza, Bianco, Paola Del, Tognon, Martina, Frasson, Chiara, Palumbo, Pietro, Ciribilli, Yari, Pfeffer, Ulrich, Carella, Massimo, Amadori, Alberto, Indraccolo, Stefano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ferrata Storti Foundation 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7193477/
https://www.ncbi.nlm.nih.gov/pubmed/31467126
http://dx.doi.org/10.3324/haematol.2019.217687

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7193477/
https://www.ncbi.nlm.nih.gov/pubmed/31467126
http://dx.doi.org/10.3324/haematol.2019.217687

Ejemplares similares